23.77
price up icon1.60%   0.375
after-market After Hours: 23.95 0.185 +0.78%
loading
Structure Therapeutics Inc Adr stock is traded at $23.77, with a volume of 719.49K. It is up +1.60% in the last 24 hours and down -16.14% over the past month. Structure Therapeutics Inc is a clinical-stage biopharmaceutical company aiming to develop and deliver novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its lead product candidate is GSBR-1290, an oral and biased small molecule agonist of glucagon-like-peptide-1 receptor, a validated G-protein-coupled receptors (GPCRs) drug target for type-2 diabetes mellitus and obesity. The company is also developing oral small-molecule therapeutics targeting other GPCRs for the treatment of pulmonary and cardiovascular diseases, including ANPA-0073 and LTSE-2578.
See More
Previous Close:
$23.39
Open:
$23.4
24h Volume:
719.49K
Relative Volume:
0.85
Market Cap:
$1.36B
Revenue:
-
Net Income/Loss:
$-100.44M
P/E Ratio:
-10.70
EPS:
-2.22
Net Cash Flow:
$-105.32M
1W Performance:
-2.56%
1M Performance:
-16.14%
6M Performance:
-40.05%
1Y Performance:
-42.06%
1-Day Range:
Value
$23.36
$24.87
1-Week Range:
Value
$22.33
$24.87
52-Week Range:
Value
$22.33
$62.74

Structure Therapeutics Inc Adr Stock (GPCR) Company Profile

Name
Name
Structure Therapeutics Inc Adr
Name
Phone
(628) 229-9277
Name
Address
611 GATEWAY BLVD SUITE 223, SOUTH SAN FRANCISCO
Name
Employee
148
Name
Twitter
Name
Next Earnings Date
Name
Latest SEC Filings
Name
GPCR's Discussions on Twitter

Compare GPCR with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
GPCR
Structure Therapeutics Inc Adr
23.77 1.36B 0 -100.44M -105.32M -2.22
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
484.24 124.35B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
700.33 76.56B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
644.48 39.16B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
250.59 32.44B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
BNTX
Biontech Se Adr
120.01 28.77B 3.30B -501.07M 1.03B -2.1146

Structure Therapeutics Inc Adr Stock (GPCR) Upgrades & Downgrades

Date Action Analyst Rating Change
Jan-08-25 Initiated Stifel Buy
Dec-04-24 Initiated H.C. Wainwright Buy
Sep-23-24 Initiated Morgan Stanley Overweight
May-21-24 Initiated JP Morgan Overweight
Apr-09-24 Initiated Cantor Fitzgerald Overweight
Oct-19-23 Initiated JMP Securities Mkt Outperform
Jul-27-23 Initiated Piper Sandler Overweight
May-25-23 Resumed Jefferies Buy
Feb-28-23 Initiated BMO Capital Markets Outperform
Feb-28-23 Initiated Guggenheim Buy
Feb-28-23 Initiated Jefferies Buy
Feb-28-23 Initiated SVB Securities Outperform
View All

Structure Therapeutics Inc Adr Stock (GPCR) Latest News

pulisher
Feb 20, 2025

Structure Therapeutics (NASDAQ:GPCR) Sets New 12-Month LowWhat's Next? - MarketBeat

Feb 20, 2025
pulisher
Feb 20, 2025

Structure Therapeutics Inc. (NASDAQ:GPCR) Sees Large Decline in Short Interest - MarketBeat

Feb 20, 2025
pulisher
Feb 19, 2025

GPCR Stock Hits 52-Week Low at $23.48 Amid Market Challenges - Investing.com Canada

Feb 19, 2025
pulisher
Feb 19, 2025

Structure Therapeutics (NASDAQ:GPCR) Sets New 52-Week Low – Here’s What Happened - Defense World

Feb 19, 2025
pulisher
Feb 14, 2025

Why Structure Therapeutics Stock Was Stumbling This Week - The Globe and Mail

Feb 14, 2025
pulisher
Feb 14, 2025

abrdn plc Sells 45,695 Shares of Structure Therapeutics Inc. (NASDAQ:GPCR) - MarketBeat

Feb 14, 2025
pulisher
Feb 11, 2025

Financial Fitness Check: Examining Structure Therapeutics Inc ADR (GPCR)’s Key Ratios - The Dwinnex

Feb 11, 2025
pulisher
Feb 11, 2025

Spire Wealth Management Acquires Shares of 8,949 Structure Therapeutics Inc. (NASDAQ:GPCR) - MarketBeat

Feb 11, 2025
pulisher
Feb 11, 2025

Structure Therapeutics (NASDAQ:GPCR) Trading Down 6.7%Should You Sell? - MarketBeat

Feb 11, 2025
pulisher
Feb 10, 2025

HSBC Securities Downgrades Morgan Stanley (MS) to a Hold from a Buy - Knox Daily

Feb 10, 2025
pulisher
Feb 10, 2025

JD.com Inc ADR (JD) receives an Outperform rating from Bernstein - Knox Daily

Feb 10, 2025
pulisher
Feb 07, 2025

Ratio Examination: Bausch Health Companies Inc (BHC)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex

Feb 07, 2025
pulisher
Feb 07, 2025

Brokerages Set Structure Therapeutics Inc. (NASDAQ:GPCR) PT at $81.29 - MarketBeat

Feb 07, 2025
pulisher
Feb 07, 2025

Understanding the Recent Fluctuations of Structure Therapeutics Inc ADR’s (GPCR) Stock - The News Heater

Feb 07, 2025
pulisher
Feb 06, 2025

Structure Therapeutics Inc. (NASDAQ:GPCR) Short Interest Update - MarketBeat

Feb 06, 2025
pulisher
Feb 06, 2025

CCG Wealth Management LLC Makes New $4.07 Million Investment in Structure Therapeutics Inc. (NASDAQ:GPCR) - MarketBeat

Feb 06, 2025
pulisher
Feb 06, 2025

Analysts Set Structure Therapeutics Inc. (NASDAQ:GPCR) PT at $81.29 - Defense World

Feb 06, 2025
pulisher
Feb 05, 2025

GLP-1 Agonists Weight Loss Drugs Market Size Report, 2030 - Grand View Research

Feb 05, 2025
pulisher
Feb 03, 2025

Short Interest in Structure Therapeutics Inc. (NASDAQ:GPCR) Rises By 5.8% - Defense World

Feb 03, 2025
pulisher
Feb 02, 2025

Structure Therapeutics (NASDAQ:GPCR) Stock Price Up 8.3%Still a Buy? - MarketBeat

Feb 02, 2025
pulisher
Jan 30, 2025

Structure Therapeutics Lines Up Triple Conference Appearances: What's Next for GPCR? - StockTitan

Jan 30, 2025
pulisher
Jan 30, 2025

Fidelity Electric Vehicles and Future Transportation ETF (BATS:FDRV) Shares Up 0.5% – Still a Buy? - Defense World

Jan 30, 2025
pulisher
Jan 28, 2025

Liberty TripAdvisor (NASDAQ:LTRPA) Now Covered by Analysts at StockNews.com - Defense World

Jan 28, 2025
pulisher
Jan 26, 2025

ImmuPharma (LON:IMM) Trading 13.6% Higher – Here’s What Happened - Defense World

Jan 26, 2025
pulisher
Jan 25, 2025

JPMorgan Chase & Co. Has $1.31 Million Stock Holdings in iShares International Treasury Bond ETF (NASDAQ:IGOV) - Defense World

Jan 25, 2025
pulisher
Jan 24, 2025

JPMorgan Chase & Co. Grows Position in Structure Therapeutics Inc. (NASDAQ:GPCR) - Defense World

Jan 24, 2025
pulisher
Jan 24, 2025

Air T (NASDAQ:AIRT) Shares Cross Below 200-Day Moving Average – What’s Next? - Defense World

Jan 24, 2025
pulisher
Jan 24, 2025

JPMorgan Chase & Co. Acquires 25,500 Shares of Structure Therapeutics Inc. (NASDAQ:GPCR) - MarketBeat

Jan 24, 2025
pulisher
Jan 24, 2025

Analysts Issue Forecasts for Kits Eyecare Q4 Earnings - Defense World

Jan 24, 2025
pulisher
Jan 22, 2025

Hepion Pharmaceuticals Announces $9M Public Offering with Dual Warrant Structure - StockTitan

Jan 22, 2025
pulisher
Jan 21, 2025

Morningstar Mobile - Morningstar

Jan 21, 2025
pulisher
Jan 20, 2025

2 Companies Poised to Capitalize on the Rise of GLP-1 Drugs - Morningstar

Jan 20, 2025
pulisher
Jan 18, 2025

Savills (OTCMKTS:SVLPF) Trading Down 5.2% – What’s Next? - Defense World

Jan 18, 2025
pulisher
Jan 17, 2025

Novo’s Ozempic, Wegovy Targeted for Medicare Price Cuts - BNN Bloomberg

Jan 17, 2025
pulisher
Jan 15, 2025

GAMMA Investing LLC Raises Stock Position in Structure Therapeutics Inc. (NASDAQ:GPCR) - Defense World

Jan 15, 2025
pulisher
Jan 13, 2025

Schrödinger Secures $150M Novartis Deal, Advances Three Clinical Programs for 2025 - StockTitan

Jan 13, 2025
pulisher
Jan 10, 2025

Structure Therapeutics (NASDAQ:GPCR) Hits New 1-Year LowShould You Sell? - MarketBeat

Jan 10, 2025
pulisher
Jan 10, 2025

Nucor Towers & Structures Announces Expansion of Footprint - Yahoo Finance

Jan 10, 2025
pulisher
Jan 10, 2025

Stifel Nicolaus Begins Coverage on Structure Therapeutics (NASDAQ:GPCR) - Defense World

Jan 10, 2025
pulisher
Jan 09, 2025

Structure Therapeutics Inc. (NASDAQ:GPCR) Receives Average Recommendation of "Buy" from Analysts - MarketBeat

Jan 09, 2025
pulisher
Jan 08, 2025

Stock Market Movers Today • Top Gainers & Losers - Benzinga

Jan 08, 2025
pulisher
Jan 08, 2025

Structure Therapeutics (NASDAQ:GPCR) Shares Gap UpHere's What Happened - MarketBeat

Jan 08, 2025

Structure Therapeutics Inc Adr Stock (GPCR) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$33.42
price up icon 0.27%
$81.06
price down icon 3.05%
$361.10
price down icon 1.70%
$22.12
price down icon 4.08%
biotechnology ONC
$255.37
price up icon 4.57%
$120.01
price up icon 1.81%
Cap:     |  Volume (24h):